Cargando…
Molecular Monitoring as a Path to Cure Acute Promyelocytic Leukemia
Acute promyelocytic leukemia (APL) is a molecularly well-defined disease, characterized by a specific chromosomal translocation; the improvement in biologic and clinical knowledge and subsequent introduction of molecularly targeted therapies have transformed the management of APL, with survival rate...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4837932/ https://www.ncbi.nlm.nih.gov/pubmed/27182481 http://dx.doi.org/10.1007/s40487-015-0013-8 |